Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lindsay Riley
Determining Duration of HER2-Targeted Therapy Using Stem Cell Extinction Models
PLoS ONE
Multidisciplinary
Related publications
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Targeted Delivery of Doxorubicin to HER2 Positive Tumor Models
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Cancer Cell
Cancer Research
Oncology
Cell Biology
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Cancer Cell
Cancer Research
Oncology
Cell Biology
Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Ovarian Cancer Stem Cells Express ROR1, Which Can Be Targeted for Anti–cancer-Stem-Cell Therapy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Stem Cell Therapy for Ischemic Stroke Using iPS Cells
Clinical Neurology
Neurology
Targeted Therapy for Renal Cell Carcinoma
Dynamics of Leukemia Stem-Like Cell Extinction in Acute Promyelocytic Leukemia
Cancer Research
Cancer Research
Oncology